Found 102 matching trials
A Pilot Study of Autologous Ex Vivo Activated NK Cell Infusion in the Treatment of Metastatic Nasopharyngeal Carcinoma PHASE1 1. To demonstrate the feasibility of leukapheresis and ex vivo activation o...
Show More Location
National University Hospital
Learn More & Join Trial
FT516 in Combination With Monoclonal Antibodies in Advanced Solid Tumors PHASE1 This is a Phase 1 dose-finding study of FT-516 in combination with monoclon...
Show More Location
University of Minnesota Masonic Cancer Center
Learn More & Join Trial
A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas PHASE1 This is a pilot clinical trial investigating the addition of haploidentical...
Show More Location
St. Jude Children's Research Hospital
Learn More & Join Trial
A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1) PHASE1 This is a Phase 1/2, open-label, multi-center, multi-cohort, non-randomized...
Show More Location
Nkarta Investigational Site
Learn More & Join Trial
Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors PHASE1 Phase I trial to study the effectiveness of interleukin-12, paclitaxel, and...
Show More Location
Ohio State University Medical Center
Learn More & Join Trial
A Study of Allogenic Natural Killer Cells in Combination With Trastuzumab and Pertuzumab in Adult Patients With Refractory Metastatic Her2 Positive Breast Cancer. NK-ACT-BC_2020 PHASE1 Breast cancer is the second most common invasive malignancy and the leading...
Show More Learn More & Join Trial
FT516 and IL2 With Enoblituzumab for Ovarian Cancer PHASE1 This is a single center Phase I clinical trial of FT516 administered intrap...
Show More Location
University of Minnesota, Masonic Cancer Center
Learn More & Join Trial
Haploidentical Donor Natural Killer Cell Infusion With IL-15 in Acute Myelogenous Leukemia (AML) PHASE1 This is a single center, "modified standard design" dose escalation study d...
Show More Location
Masonic Cancer Center, University of Minnesota
Learn More & Join Trial
Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma PHASE2 Phase II trial to study the effectiveness of combining interleukin-12 and i...
Show More Location
Cancer and Leukemia Group B
Learn More & Join Trial
Safety and Preliminary Efficacy of JK500 Cell Injection in Relapsed/Refractory Pediatric Acute Myeloid Leukemia EARLY_PHASE1 This study is a prospective, single-center, single-arm exploratory clinical...
Show More Location
Department of Pediatrics, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences
Learn More & Join Trial